Molecular analysis of a public cross-neutralizing antibody response to SARS-CoV-2

Keyphrases

• Molecular Analysis 100%
• Neutralizing Antibodies 100%
• COVID-19 100%
• Cross-neutralizing Antibody 100%
• Receptor-binding Domain 66%
• COVID-19 Vaccine 66%
• Variants of Concern 66%
• Amino Acids 33%
• Amino Acid Residues 33%
• Published Data 33%
• Population Level 33%
• Antibody Response 33%
• Complementarity-determining Region 3 (CDR3) 33%
• Generation Design 33%
• Allelic Polymorphism 33%
• Domain Antibody 33%
• Heterogenity 33%
• Germline Gene 33%
• Severe Acute Respiratory Syndrome Coronavirus 2 Variants 33%
• Public Antibody 33%
• Paratope 33%

Immunology and Microbiology

• Antibody Response 100%
• Neutralizing Antibody 100%
• Severe Acute Respiratory Syndrome Coronavirus 2 100%
• Monospecific Antibody 50%
• Vaccine Efficacy 50%
• Receptor Binding 50%
• COVID-19 50%
• Lineages 25%
• Paratope 25%
• Complementarity Determining Region 25%
• Omicron Coronavirus Variant 25%